|
|
|
| home > white papers > Pandemic respiratory vaccine clinical trials: a departure from business as usual - ICON plc |
|
|
 WHITE PAPERS |
|
ICON plc
|
|
Pandemic respiratory vaccine clinical trials: a departure from business as usual
|
|
Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Synthego Launches Engineered Cell Libraries to Validate Targets with Speed and Accelerate Drug Discovery
Aug 02, REDWOOD CITY, Calif. – Synthego, the genome engineering
company, today announced the launch of Engineered Cell Libraries, a
novel offering that further enables access to CRISPR by providing
arrayed CRISPR-edited cells for direct use in functional screening
assays. The innovative solution leverages Synthego’s Eclipse™ Platform.
This high-throughput cell engineering platform delivers cell-based
models for disease research by providing highly predictable
CRISPR-engineered cells at scale through the integration of engineering,
bioinformatics, and proprietary science. Synthego’s Engineered Cell
Libraries provide unparalleled speed, scalability, and efficiency to
accelerate the drug discovery process by enabling a faster path between
experimental design and execution.
More info >> |
|
 |
White Papers |
 |
|
 |
Industry Events |
 |
Connect in Pharma
14-15 September 2022, Plaexpo, Geneva, Switzerland
The new event driving innovation for pharma and biopharma businesses,
Connect in Pharma will unite key players in Pharmaceutical and
Biopharmaceutical packaging and production in Geneva on 14 – 15
September 2022.
More info >> |
|
|
|
